AOL Money & Finance

CVS posts

Rite Aid beats analysts, but not right for me yet

Rite Aid (NYSE: RAD), which competes with Walgreen (NYSE: WAG), CVS Caremark (NYSE: CVS), and Wal-Mart (NYSE: WMT), saw a big increase in volume on Wednesday after it reported earnings for the first quarter. In fact, as Douglas McIntyre observed, shares of Rite Aid were up 5% at one point during yesterday's session. However, the shares ended up losing their green status by the close of trading. Rite Aid actually lost 3% when all was said and done. What does it all mean?

Well, Rite Aid did beat analyst forecasts by a wide margin. The call was for a loss of 13 cents per share. Rite Aid lost only 6 cents per share once adjustments are made. Revenues dipped a little over 1%, and same-store sales, after excluding the effect of the Brooks Eckerd acquisition, increased 1.5%. Interestingly, the mix of this increase is as follows: the pharmacy sales went up 3.1% on a comparable basis, and the non-pharmacy sales went down 1.4% on the same basis.

Continue reading Rite Aid beats analysts, but not right for me yet

The week in preview: End-of-quarter earnings expectations: Nike, Oracle, Walgreen ...

This week brings a small flurry of end-of-the-calendar-quarter earnings reports. And for the most part, the expectations of the analysts surveyed by Thomson Reuters aren't very high. Companies expected to report declining earnings in the most recently concluded quarter include America's Car-Mart Inc. (NASDAQ: CRMT), Bed Bath & Beyond Inc. (NASDAQ: BBBY), ConAgra Foods Inc. (NYSE: CAG), Jabil Circuit Inc. (NYSE: JBL), Jackson Hewitt Tax Service Inc. (NYSE: JTX), Monsanto Co. (NYSE: MON), and Sonic Corp. (NASDAQ: SONC).

Continue reading The week in preview: End-of-quarter earnings expectations: Nike, Oracle, Walgreen ...

Walgreen to report Q3 numbers: What should we look for?

Walgreen (NYSE: WAG), a drugstore business that competes with CVS Caremark (NYSE: CVS) and Rite-Aid (NYSE: RAD), will be issuing results for the third quarter on Monday, June 22. According to Earnings.com, the analyst community is prescribing $0.56 per share for the company.

Of course, the question is: will Walgreen honor that prescription and fill it? I'd say it's quite possible. Last time around, Walgreen beat estimates. The call was for $0.66 per share in Q2. If you look at the press release from that time, you'll see that, once you adjust for some items, Walgreen went beyond expectations.

Continue reading Walgreen to report Q3 numbers: What should we look for?

The week in preview: May flowers, earnings, and more

Along with the May flowers, the coming week will bring plenty more disappointing earnings reports. Analysts surveyed by Thomson Reuters anticipate that Archer Daniels Midland Co. (NYSE: ADM), CBS Corp. (NYSE: CBS), Cisco Systems Inc. (NASDAQ: CSCO), CVS Caremark Corp. (NYSE: CVS), Kraft Foods Inc. (NYSE: KFT), and Walt Disney Co. (NYSE: DIS) will all post lower earnings for the most recent quarter. American International Group Inc. (NYSE: AIG) and Sprint Nextel Corp. (NYSE: S) are expected to report losses.

But which companies are doing well? Here are a few reporting this week that analysts are optimistic about.

Continue reading The week in preview: May flowers, earnings, and more

Analyst upgrades, downgrades and initiations: KWK, BCS, CVS, BAC ...

Analyst upgrades:
  • Jefferies upgraded Quicksilver (NYSE: KWK) to Buy from Hold as it believes the company has many options to resolve its liquidity crisis. The firm expects shares to move towards its $10 NAV estimate and raised its target price to $10 from $7.
  • Deutsche Bank upgraded Omnicom Group (NYSE: OMC) to Hold from Sell following the Q1 results as the company's margins are holding up better than previously thought. The firm raised its target price on shares to $31 from $21.
  • Deutsche Bank also upgraded Universal Health (NYSE: UHS) following the company's better than expected Q1 results. Shares were lifted to Buy from Hold and the firm raised its target on the stock to $60 from $45.
  • Barclays (NYSE: BCS) was raised to Buy from Reduce at Nomura.
  • Orient-Express (NYSE: OEH) was lifted to Neutral from Underweight at JP Morgan.
  • CVS Caremark (NYSE: CVS) was upgraded at Goldman to Conviction Buy from Buy.

Continue reading Analyst upgrades, downgrades and initiations: KWK, BCS, CVS, BAC ...

Don't fear the swine flu . . . trade it

I remember Toronto during SARS. As one of the harder hit areas, it was not a happy place. It was the end of winter, but that miserable, cold winter just didn't want to end. People walked the streets in a gloomy haze, afraid to take the subway and giving dirty looks to anyone brazen enough to cough in public. Worse, I couldn't even visit a friend in the hospital. All things considered though, in global pandemic terms, it was over relatively quickly. Let's hope swine flu will be the same.

In the meantime, let's put on our investors hats and see what's in store for some stocks:

Travel and tourist stocks
This is one of the worst hit areas, especially airlines, as people may cancel their travel plans. For example, AMR Corp. (NYSE: AMR) traded over 9 percent lower an hour after the open. Royal Caribbean Cruises (NYSE: RCL) was down over 15 percent. In fact UBS downgraded these airlines and hotels this morning: AMR, Continental Airlines (NYSE: CAL), Host Hotels and Resorts (NYSE: HST), Lasalle Hotel Properties (NYSE: LHO), Marriott (NYSE: MAR), United Airlines (NASDAQ: UAUA), US Airways (NYSE: LCC). Carnival Cruise Lines (NYSE: CCL) also declined considerably. Best to stay away from the sector.

Continue reading Don't fear the swine flu . . . trade it

Cramer on BloggingStocks: The seductive pull of the early cycle

TheStreet.com's Jim Cramer is seeing signs of a coming boom, but he's still being cautious here.

If you had to define the early cycle, if you had to outline what stocks should be soaring coming out of a recession into a boom and which ones should be faltering, you would have to say the action in this market in the last month is the quintessential behavioral pattern.

What are the components of the early cycle? First, it's the homebuilders. As is typical coming out of a recession, the stocks precede the bottom of housing. That's exactly what's happening with the lowest permits and highest affordability and best mortgage rates and massive inventory. Everywhere, except on Wall Street reporting, the bottom is bursting out. When you read the lead story in the Sunday Philadelphia Inquirer, and it is all about the thousands of prospective homebuyers heading south to pick up condos and homes for half of what they were worth two years ago -- or even less -- and you know that virtually no one has broken ground in the Sunshine State in a year, you can bet that the bottom's actually behind us. This housing market has wiped out all but the most stable private builders and even the public ones are merging as we know from Pulte (NYSE: PHM) (Cramer's Take) and Centex (NYSE: CTX) (Cramer's Take). So, in the next cycle, you can see some profitability developing year over year even though the new homes don't have much margin because the foreclosed homes next door are going for a song. And don't believe this won't change the dynamic of future foreclosures. In most areas, rent is higher than the interest on mortgages, so you will find that second or third job needed to stay in your home. The incentive structure's radically different than a year ago.

Continue reading Cramer on BloggingStocks: The seductive pull of the early cycle

Rite Aid up on Q4 report -- can you buy it now?

Rite Aid (NYSE: RAD), whose competitors include Walgreen (NYSE: WAG), CVS Caremark (NYSE: CVS), and Wal-Mart (NYSE: WMT), reported Q4 numbers today, and when you read through the release, you sort of come away with a decent feeling. You hear about improvements in this metric and that metric. You wonder if a turnaround might be in the offing. Then you look at the stock price and, even though it is currently being bid higher (it's up over 14% as I write), you come back down to earth and reality hits you in the face. Anything trading under a buck has to give you pause. Rite Aid is no different.

For the quarter, Rite Aid posted a 1.7% decrease in the top line. On an adjusted basis, the drugstore chain reported a loss of $0.14 per share. According to this source, Wall Street thought Rite Aid might lose $0.105 per share. The company is still adjusting to the Brooks Eckerd acquisition. Excluding that effect, same-store sales increased 0.8%. Including the asset, comps decreased 0.1%.

Continue reading Rite Aid up on Q4 report -- can you buy it now?

Earnings highlights: Walmart, Comcast, CVS, Sprint, Hormel, Priceline and more

Here are some highlights from this past week's earnings coverage from BloggingStocks:

Continue reading Earnings highlights: Walmart, Comcast, CVS, Sprint, Hormel, Priceline and more

CVS Caremark jumps on earnings; options traders hone in

CVS Caremark logoCVS Caremark Corporation (NYSE: CVS) is enjoying a 6% jump higher today on the heels of this morning's earnings report. The pharmaceutical retailer banked $935 million (65 cents per share) during the fourth-quarter reporting period. This is up nearly 17% from earnings in the year-earlier period.


Continue reading CVS Caremark jumps on earnings; options traders hone in

Stocks in the news: HPQ, S, UBS, WFMI, CROX, CBS, PCLN, LDK, CVS

U.S. stock futures were higher Thursday morning, pointing to a stronger start on Wall Street as investors continued to focus on the economy. Before the bell: Futures point to higher start ahead of economic data

Hewlett-Packard Corp. (NYSE: HPQ), reported a 13% quarterly drop in earnings as sales ticked up just 1% due to the recession. Results were inline with estimates, and even though it cut its 2009 guidance, it was still in line with Wall Street's expectations. HPQ shares declined 3.4% in premarket trade.

Sprint Nextel Corp (NYSE: S) posted a $1.6 billion, or 57 cents per share quarterly loss on Thursday and said a total of 1.3 million wireless customers had left its service during the quarter. Revenue fell to $8.4 billion from $9.8 billion a year earlier, and topped the Street's estimate. Sprint expects subscriber losses to improve in 2009. Sprint shares are soaring some 6.6% in premarket trading.

Continue reading Stocks in the news: HPQ, S, UBS, WFMI, CROX, CBS, PCLN, LDK, CVS

CVS knows that a doctor's handwriting is a code for earnings

As drug store chains go, there are few better than CVS Caremark, with the chain taking the CVS name. Further, with the U.S. recession in its 15th month and shares doing their best to form a bottom, now is the time to scoop up CVS's shares, for several reasons.

First, CVS (NYSE: CVS) is a classic defensive stock. During recessions, and especially during this recession, consumers cut back spending, but they do their best to maintain essential purchases, and prescriptions are one such purchase. That bodes well for what analysts call "back store revenue" (the pharmacy).

Continue reading CVS knows that a doctor's handwriting is a code for earnings

Earnings highlights: Citigroup, Intel, JPMorgan, Alcoa, Apple and others

Here are some highlights from this past week's earnings coverage from BloggingStocks:

Continue reading Earnings highlights: Citigroup, Intel, JPMorgan, Alcoa, Apple and others

Walgreen looking for growth with wellness network

Walgreen (NYSE: WAG ) knows that people want all kinds of options to meet their healthcare needs. Walgreen also knows that it needs to grow and keep up with competitor CVS Caremark (NYSE: CVS) and the pharmacy department at Wal-Mart (NYSE: WMT). And, yes, I suppose Rite-Aid (NYSE: RAD) is technically a competitor, too, although you wouldn't know it by that drugstore chain's stock price. Well, according to The Wall Street Journal, Walgreen plans to promote an initiative called "Complete Care and Well-Being" to employers. The goal here is to give corporate, as well as government, employees and their families access to healthcare services such as preventive medicine and dental examinations in off-hour time periods. Walgreen will use a network of in-store clinics and health centers to provide these services. That's pretty cool, right? Well, one of the bigger benefits to Walgreen is the synergy it can promote by leveraging this program.

Continue reading Walgreen looking for growth with wellness network

Closing Bell: Dow sinks another 248 points; ORCL, CVS, COP, C, GE

Today was yet another lower trading day straight from the start. If we get another couple days in a row like that, we'll start hearing "I owe, I owe, off to sell stocks I go." Retail sales were expected to be dismal, which they were. And the Beige Book held very little promise or hope.

Here are today's numbers:
DJIA: 8,200.14 -248.42 -2.94%
NASDAQ: 1,489.64 -56.82 -3.67%
S&P 500: 842.62 -29.17 -3.35%
Top Analyst Upgrades
Top Analyst Downgrades

Oracle Corp. (NASDAQ: ORCL) was weak all day after being noted in the WSJ as having cut about 500 positions in its North American sales and consulting businesses. Shares were down almost 5% at $16.33 late in the day.

CVS Caremark Corp. (NYSE: CVS) approved an 11% increase to its quarterly dividend despite the company having cut its 2009 guidance just last week, Shares, though, fell with the market and were down almost 3% at $25.93 late in the day.

Continue reading Closing Bell: Dow sinks another 248 points; ORCL, CVS, COP, C, GE

Next Page >

Symbol Lookup
IndexesChangePrice
DJIA-0.458,177.96
NASDAQ+7.231,754.40
S&P 500+2.41881.97

Last updated: July 09, 2009: 04:01 PM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

WalletPop Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance